期刊文献+

正性肌力药物在收缩性心力衰竭中的临床应用进展 被引量:2

Progress on the treatment of children's systolic heart failure by positive inotropic drugs
原文传递
导出
摘要 儿童心力衰竭是一种儿科常见危重症。收缩性心力衰竭可由先天性心脏病、暴发性心肌炎、心律失常性心肌病等儿科常见心血管疾病引起。正性肌力药物是临床中治疗收缩性心力衰竭的常用药物,包括洋地黄类药物、β-受体激动剂、磷酸二酯酶抑制剂及钙增敏剂4种。本文将对各类正性肌力药物的应用及进展进行探讨。 Heart failure is a common critical disease in children. Systolic heart failure can be caused by common diseases in children such as congenital heart disease, fulminant myocarditis and arrhythmogenic cardiomyopathy. Positive inotropic drug is the most common medication for treating systolic heart failure in children. Common inotropic drug includes digitalis, β-receptor agonist, phosphodiesterase inhibitor and calci- um sensitizers. This article reviewed the using and progress of positive inotopic drugs.
作者 袁越 甄珍
出处 《中国小儿急救医学》 CAS 2013年第5期455-458,共4页 Chinese Pediatric Emergency Medicine
关键词 正性肌力药物 收缩性心力衰竭 Positive inotropic drug Systolic heart failure
  • 相关文献

参考文献11

  • 1Leonard S. Pathophysiology of heart disease. 5th edition. USA: Lippincott Williams & Wilkins ,2011:201.
  • 2Gheorghiade M, Braunwald E. Reconsidering the role for digox- in in the management of acute heart failure syndromes. JAMA, 2009,302(19) :2146-2147.
  • 3胡亚美 江载芳.诸福棠实用儿科学7版[M].北京:人民卫生出版社,2002.441.
  • 4Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diag- nosis and treatment of chronic heart failure:executive summary ( update 2005 ). Eur Heart J,2005,6 ( 11 ) : 1115-1140.
  • 5急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:835
  • 6Hoffman TM, Wemovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in in- fants and children after corrective surgery for congenital heart disease. Circulation, 2003,107 ( 7 ) :996-1002.
  • 7Vazir A,Leaver N, Lyster H, et al. Is monitodng milrinone therapy useful in advanced heart failure?, Int J Cardiol,2011,149(3) :380-381.
  • 8Cuffe MS, Calliff RM, Adams KF, et al. Short-term intravenous milrinone for the acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA,2002,287 ( 12 ) : 1541-1547.
  • 9Sukoyan GV, Gongadze NV. Mechanism of cardioprotective effect of adenocine and non-glycoside cardiotonic drugs during experimental chronic cardiac insufficiency. Bull Exp Biol Med, 2011,150(5) :610-613.
  • 10Namachivayam P, Crossland DS, Butt WW, et al. Early experi- ence with Levosimendan in children with ventricular dysfunc- tion. Pediatr Crit Care Med, 2006,7 ( 5 ) :445-448.

二级参考文献39

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
  • 9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.
  • 10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845.

共引文献1003

同被引文献13

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部